M&A Deal Summary

Caidya Acquires Worldwide Clinical Research

On October 23, 2009, Caidya acquired life science company Worldwide Clinical Research

Acquisition Highlights
  • This is Caidya’s 1st transaction in the Life Science sector.
  • This is Caidya’s 1st transaction in the United States.
  • This is Caidya’s 1st transaction in Kansas.

M&A Deal Summary
Date 2009-10-23
Target Worldwide Clinical Research
Sector Life Science
Buyer(s) Caidya
Deal Type Add-on Acquisition

Target

Worldwide Clinical Research

Overland Park, Kansas, United States
Worldwide Clinical Research, Inc. is a contract research organization (CRO) specializing in the management of clinical studies for biotechnology and pharmaceutical companies.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Caidya

Morrisville, North Carolina, United States
Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya is a proprietary clinical technology to ensure trial transparency and data-driven decision-making. Caidya was founded in 2003 and is based in Morrisville, North Carolina.

DEAL STATS #
Overall 1 of 7
Sector (Life Science) 1 of 7
Type (Add-on Acquisition) 1 of 6
State (Kansas) 1 of 1
Country (United States) 1 of 3
Year (2009) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-01 Regulus Pharmaceutical Consulting

Boulder, Colorado, United States

Regulus Pharmaceutical Consulting, Inc. is a provider of Regulatory Affairs and Quality Assurance services.

Buy -
Mergr

Product

Company

Legal